Literature DB >> 19883515

The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan.

Nisso Kasymova1, Benjamin Johns, Benusrat Sharipova.   

Abstract

BACKGROUND: Targeted outreach, counselling, and treatment of sexually transmitted infections (STIs) are among the most cost-effective interventions aimed at ameliorating the burden of HIV/STIs. Since many new HIV infections occur in people under the age of 25, youth, and especially most at risk adolescents (MARA), need to be able to access HIV/STI services. Starting in 2006, a programme targeting MARA including outreach, confidential and voluntary counselling and testing, and STI diagnosis and treatment was piloted in three cities in Tajikistan. This study uses data from these pilot sites to estimate the costs of a national programme.
METHODS: Cost data were collected from the three pilot sites. Then, the target population and the number of patients receiving specific types of services are calculated for other areas. The unit costs from the pilot sites are multiplied by usage rates to determine the total costs of a national programme. Scenarios were developed to reflect data uncertainty. The government's ability to finance the programme was estimated using Ministry of Health budget data. Further analyses were done for one of the pilot cities where more detailed data were available.
RESULTS: In total, costs were projected for eight programme sites, covering an estimated 8,020 MARA. Operational and variable cost for the programme are projected to be US$ 119,159 (range US$ 104,953 to 151,524) per year. Including annual equivalent cost for capital and start-up items raises this to US$ 137,082 (range: US$ 123,022 to 169,597) per year. The analyses of potential sources of financing for the programme remain inconclusive, but it may take multiple sources of financing to fund the programme.
CONCLUSION: While the cost-effectiveness of similar programmes have been previously assessed using modelled data, more work needs to be done to assess the costs of new programmes in relation to financial resources available. Full costing should consider cost-savings as well as expenditures. If feasible, the impact of the programme should be monitored over time.

Entities:  

Year:  2009        PMID: 19883515      PMCID: PMC2780377          DOI: 10.1186/1478-7547-7-19

Source DB:  PubMed          Journal:  Cost Eff Resour Alloc        ISSN: 1478-7547


  16 in total

1.  The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: simulations of Uganda.

Authors:  E L Korenromp; R Bakker; R Gray; M J Wawer; D Serwadda; J D F Habbema
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

Review 2.  Evaluation of current strategies and future priorities for improving health in developing countries.

Authors:  David B Evans; Stephen S Lim; Taghreed Adam; Tessa Tan-Torres Edejer
Journal:  BMJ       Date:  2005-11-10

3.  Does scale matter? The costs of HIV-prevention interventions for commercial sex workers in India.

Authors:  Lorna Guinness; Lilani Kumaranayake; Bhuvaneswari Rajaraman; Girija Sankaranarayanan; Gangadhar Vannela; P Raghupathi; Alex George
Journal:  Bull World Health Organ       Date:  2005-11-10       Impact factor: 9.408

4.  Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.

Authors:  Daniel R Hogan; Rob Baltussen; Chika Hayashi; Jeremy A Lauer; Joshua A Salomon
Journal:  BMJ       Date:  2005-11-10

5.  Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa.

Authors:  E Marseille; J G Kahn; K Billinghurst; J Saba
Journal:  Soc Sci Med       Date:  2001-01       Impact factor: 4.634

6.  Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004.

Authors:  Julie A Stachowiak; Farida K Tishkova; Steffanie A Strathdee; Mark A Stibich; Alisher Latypov; Vladimir Mogilnii; Chris Beyrer
Journal:  Drug Alcohol Depend       Date:  2006-04       Impact factor: 4.492

7.  The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries.

Authors:  John Stover; Stefano Bertozzi; Juan-Pablo Gutierrez; Neff Walker; Karen A Stanecki; Robert Greener; Eleanor Gouws; Catherine Hankins; Geoff P Garnett; Joshua A Salomon; J Ties Boerma; Paul De Lay; Peter D Ghys
Journal:  Science       Date:  2006-02-02       Impact factor: 47.728

8.  A cost function for HIV prevention services: is there a 'u' - shape?

Authors:  Lorna Guinness; Lilani Kumaranayake; Kara Hanson
Journal:  Cost Eff Resour Alloc       Date:  2007-11-05

9.  The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania.

Authors:  Joseph D Njau; Catherine A Goodman; S Patrick Kachur; Jo Mulligan; John S Munkondya; Naiman McHomvu; Salim Abdulla; Peter Bloland; Anne Mills
Journal:  Malar J       Date:  2008-01-07       Impact factor: 2.979

10.  Programme costs in the economic evaluation of health interventions.

Authors:  Benjamin Johns; Rob Baltussen; Raymond Hutubessy
Journal:  Cost Eff Resour Alloc       Date:  2003-02-26
View more
  2 in total

1.  The costs of scaling up HIV and syphilis testing in low- and middle-income countries: a systematic review.

Authors:  Rabiah Al Adawiyah; Olga P M Saweri; David C Boettiger; Tanya L Applegate; Ari Probandari; Rebecca Guy; Lorna Guinness; Virginia Wiseman
Journal:  Health Policy Plan       Date:  2021-06-25       Impact factor: 3.344

2.  HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya.

Authors:  Omar Galárraga; Richard G Wamai; Sandra G Sosa-Rubí; Mercy G Mugo; David Contreras-Loya; Sergio Bautista-Arredondo; Helen Nyakundi; Joseph K Wang'ombe
Journal:  Health Policy Plan       Date:  2017-12-01       Impact factor: 3.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.